PD-1 and topoisomerase I — Drug Target

All drugs that target PD-1 and topoisomerase I — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

PD-1 inhibitor and topoisomerase I inhibitor

Phase 2 pipeline (1)

• CMAB009 plus Irinotecan · Shanghai Zhangjiang Biotechnology Limited Company · PD-1 inhibitor and topoisomerase I inhibitor · Oncology
  CMAB009 is a PD-1 inhibitor, and Irinotecan is a topoisomerase I inhibitor.